Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma

Cancer Research

Volumn 62, Issue 17, 2002, Pages 5106-5114

  Mills, Lisa ^a   Tellez, Carmen ^a   Huang, Suyun ^a   Baker, Cheryl ^a   McCarty, Marya ^a   Green, Larry ^b   Gudas, Jean M ^b   Feng, X ^b   Bar Eli, Menashe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Abgenix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABX MA1; CANCER ANTIBODY; COLLAGENASE; GELATINASE A; MATRIGEL; MUCIN; MUCIN 18; MUCIN 18 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL LINE; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPHEROID CELL; THICKNESS; TUMOR GROWTH; TUMOR VASCULARIZATION; UMBILICAL VEIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, CD146; ANTIGENS, SURFACE; CELL ADHESION; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOGLOBULIN G; MALE; MATRIX METALLOPROTEINASE 2; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; NEURAL CELL ADHESION MOLECULES; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036735301     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Metastasis results from pre-existing variant cell within a malignant tumor
2. Clinical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes Memorial Award Lecture
3. 3 on human melanoma cells
4. Cell adhesion receptor expression during melanoma progression and metastasis
5. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease
6. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation
7. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 76, 000
8. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily
9. Genomic organization of the melanoma-associated glycoprotein MUC 18: Implications for the evolution of the immunoglobulin domains
10. BEN a surface molecule of the immunoglobulin superfamily expressed in a variety of developing systems
11. Neural cell adhesion molecule: Structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing
12. Molecular biology of cell adhesion in neural development
13. Identification of a chromosome 18q gene that is altered in colorectal cancers
14. Isolation and functional characterization of the A32 melanoma-associated antigen
15. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
16. Prognostic factors for cutaneous melanoma
17. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes
18. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells
19. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis
20. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: Evidence for a dominant phenotype
21. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice
22. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites
23. Specific organ metastasis of human melanoma cells injected into the arterial circulation of nude mice
24. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
25. INK4/MTS-1) gene in human melanoma cells: Relevance to tumor growth and metastasis
26. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice
27. Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: Comparisons with the parent tumor xenografts
28. Acquired multicellular-mediated resistance to alkylating agents in cancer
29. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53
30. Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis
31. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92-and 72-kDa enzyme genes in HT-1080 cells
32. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo
33. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
34. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo
35. Loss of AP-2 results in upregulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells
36. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
37. The implications of angiogenesis for the biology and therapy of cancer metastasis
38. bFGF as a autocrine growth factor for human melanoma
39. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
40. Enhanced expression of vascular endothelial growth factor in metastatic melanoma
41. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
42. Monoclonal antibody therapy
43. Antibody therapy of lymphoma
44. The EGF receptor family as targets for cancer therapy
45. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy
46. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
47. Expression of a human cell adhesion molecule, MUC18 in prostate cancer cell lines and tissues